VanEck Associates’s Ducommun DCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.2M Buy
427,603
+173,616
+68% +$25.8M 0.05% 212
2026
Q1
$31M Buy
253,987
+67,152
+36% +$8.03M 0.02% 346
2025
Q4
$17.8M Buy
186,835
+82,859
+80% +$7.72M 0.01% 421
2025
Q3
$9.99M Buy
103,976
+54,726
+111% +$4.95M 0.01% 546
2025
Q2
$4.07M Sell
49,250
-6,268
-11% -$417K ﹤0.01% 795
2025
Q1
$3.22M Buy
55,518
+34,568
+165% +$2.18M ﹤0.01% 866
2024
Q4
$1.33M Buy
20,950
+14,334
+217% +$921K ﹤0.01% 993
2024
Q3
$411K Buy
6,616
+2,038
+45% +$128K ﹤0.01% 1112
2024
Q2
$266K Sell
4,578
-542
-11% -$30.3K ﹤0.01% 1156
2024
Q1
$263K Buy
5,120
+63
+1% +$3.14K ﹤0.01% 1140
2023
Q4
$263K Sell
5,057
-1,537
-23% -$75.1K ﹤0.01% 1133
2023
Q3
$287K Sell
6,594
-132
-2% -$5.99K ﹤0.01% 1110
2023
Q2
$293K Buy
6,726
+3,504
+109% +$165K ﹤0.01% 1125
2023
Q1
$176K Sell
3,222
-110
-3% -$6K ﹤0.01% 1183
2022
Q4
$166K Sell
3,332
-2,560
-43% -$122K ﹤0.01% 1143
2022
Q3
$234K Buy
5,892
+2,331
+65% +$104K ﹤0.01% 1003
2022
Q2
$153K Buy
+3,561
New +$171K ﹤0.01% 1127

Other funds holding DCO

VanEck Associates's DCO Position: Q2 2026 in Review

VanEck Associates increased its Ducommun (DCO) stake by 68% in Q2 2026, buying an estimated $25.8M and bringing the position to 427,603 shares worth $79.2M. The position accounts for 0.05% of the portfolio, ranked #212.

VanEck Associates first reported a position in DCO in Q2 2022 and has held it in 17 quarters since. 270 funds tracked by Wall St. Rank hold DCO as of Q2 2026.

  • VanEck Associates held 427,603 shares of Ducommun worth $79.2M as of Q2 2026.
  • VanEck Associates bought 173,616 Ducommun shares in Q2 2026, an estimated $25.8M.
  • Ducommun made up 0.05% of VanEck Associates's portfolio in Q2 2026, its #212 holding.
  • VanEck Associates first reported a position in Ducommun in Q2 2022 and has held it in 17 quarters since.
  • 270 funds tracked by Wall St. Rank held Ducommun as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.